Open Label Study Investigating the Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
Brief description of study
The main purpose of this study is to find out if the experimental drug roxadustat (also known as FG-4592) is safe and effective for potentially treating anemia in people receiving chemotherapy treatments for cancer.
In order to take part in this study, participant must have anemia (as confirmed
by a blood test), and must have received a few chemotherapy treatments,
which the study doctor thinks is the cause of anemia. Participant must also
meet other study requirements to qualify for the study.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
cancer,anemia
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
10 Sep 2020.
Study ID: 834078
